nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—MAPT—Notch Signaling Pathway—EP300—salivary gland cancer	0.00423	0.00423	CbGpPWpGaD
Lansoprazole—CYP2C19—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00422	0.00422	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—MAP2K2—salivary gland cancer	0.00421	0.00421	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00416	0.00416	CbGpPWpGaD
Lansoprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.00414	0.00414	CbGpPWpGaD
Lansoprazole—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00412	0.00412	CbGpPWpGaD
Lansoprazole—CYP2C18—FOXA1 transcription factor network—CREBBP—salivary gland cancer	0.00408	0.00408	CbGpPWpGaD
Lansoprazole—MAPT—LKB1 signaling events—TP53—salivary gland cancer	0.004	0.004	CbGpPWpGaD
Lansoprazole—MAPT—IL-2 Signaling Pathway—HRAS—salivary gland cancer	0.0039	0.0039	CbGpPWpGaD
Lansoprazole—CYP2C9—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00385	0.00385	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—MAP2K2—salivary gland cancer	0.00372	0.00372	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00371	0.00371	CbGpPWpGaD
Lansoprazole—MAPT—Copper homeostasis—PIK3CA—salivary gland cancer	0.00356	0.00356	CbGpPWpGaD
Lansoprazole—MAPT—Copper homeostasis—TP53—salivary gland cancer	0.00344	0.00344	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-2-alpha transcription factor network—CREBBP—salivary gland cancer	0.00337	0.00337	CbGpPWpGaD
Lansoprazole—MAPT—Kit receptor signaling pathway—HRAS—salivary gland cancer	0.00297	0.00297	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—CDH1—salivary gland cancer	0.00292	0.00292	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.00287	0.00287	CbGpPWpGaD
Lansoprazole—MAPT—LPA receptor mediated events—HRAS—salivary gland cancer	0.00279	0.00279	CbGpPWpGaD
Lansoprazole—CYP2C18—FOXA1 transcription factor network—EP300—salivary gland cancer	0.00278	0.00278	CbGpPWpGaD
Lansoprazole—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00254	0.00254	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.00249	0.00249	CbGpPWpGaD
Lansoprazole—MAPT—Alzheimers Disease—TP53—salivary gland cancer	0.00246	0.00246	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00238	0.00238	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-2-alpha transcription factor network—EP300—salivary gland cancer	0.00229	0.00229	CbGpPWpGaD
Lansoprazole—CYP4A11—PPARA activates gene expression—CREBBP—salivary gland cancer	0.00224	0.00224	CbGpPWpGaD
Lansoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.00224	0.00224	CbGpPWpGaD
Lansoprazole—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—salivary gland cancer	0.0022	0.0022	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.00198	0.00198	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.00198	0.00198	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.00198	0.00198	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.00184	0.00184	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.00178	0.00178	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.0017	0.0017	CbGpPWpGaD
Lansoprazole—ABCG2—Fluoropyrimidine Activity—TP53—salivary gland cancer	0.00168	0.00168	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ISYNA1—salivary gland cancer	0.00162	0.00162	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00161	0.00161	CbGpPWpGaD
Lansoprazole—CYP4A11—PPARA activates gene expression—EP300—salivary gland cancer	0.00153	0.00153	CbGpPWpGaD
Lansoprazole—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—salivary gland cancer	0.00151	0.00151	CbGpPWpGaD
Lansoprazole—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—salivary gland cancer	0.0015	0.0015	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—HRAS—salivary gland cancer	0.00146	0.00146	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00144	0.00144	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—TP53—salivary gland cancer	0.00144	0.00144	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ISYNA1—salivary gland cancer	0.00141	0.00141	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.00135	0.00135	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.00135	0.00135	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TP53—salivary gland cancer	0.00135	0.00135	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—MARCKS—salivary gland cancer	0.00132	0.00132	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00129	0.00129	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.00126	0.00126	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PYGB—salivary gland cancer	0.00122	0.00122	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.00122	0.00122	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.00122	0.00122	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.00121	0.00121	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—MARCKS—salivary gland cancer	0.00115	0.00115	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00109	0.00109	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PYGB—salivary gland cancer	0.00107	0.00107	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.00107	0.00107	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ISYNA1—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Lansoprazole—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—salivary gland cancer	0.00103	0.00103	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PHGDH—salivary gland cancer	0.000998	0.000998	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.000977	0.000977	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ST3GAL4—salivary gland cancer	0.000961	0.000961	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ISYNA1—salivary gland cancer	0.000947	0.000947	CbGpPWpGaD
Lansoprazole—CYP1A1—PPARA activates gene expression—CREBBP—salivary gland cancer	0.00089	0.00089	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AQP1—salivary gland cancer	0.000873	0.000873	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PHGDH—salivary gland cancer	0.000873	0.000873	CbGpPWpGaD
Lansoprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—salivary gland cancer	0.000872	0.000872	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000866	0.000866	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—MARCKS—salivary gland cancer	0.000849	0.000849	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ST3GAL4—salivary gland cancer	0.00084	0.00084	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.000834	0.000834	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PYGB—salivary gland cancer	0.000789	0.000789	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.000781	0.000781	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.000777	0.000777	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.000777	0.000777	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—MARCKS—salivary gland cancer	0.000772	0.000772	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AQP1—salivary gland cancer	0.000763	0.000763	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.000729	0.000729	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PYGB—salivary gland cancer	0.000718	0.000718	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—NUP62—salivary gland cancer	0.000692	0.000692	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—VCAN—salivary gland cancer	0.000687	0.000687	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PHGDH—salivary gland cancer	0.000643	0.000643	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ISYNA1—salivary gland cancer	0.000641	0.000641	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ST3GAL4—salivary gland cancer	0.000619	0.000619	CbGpPWpGaD
Lansoprazole—CYP1A1—PPARA activates gene expression—EP300—salivary gland cancer	0.000606	0.000606	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—NUP62—salivary gland cancer	0.000605	0.000605	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000603	0.000603	CbGpPWpGaD
Lansoprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—salivary gland cancer	0.000601	0.000601	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—VCAN—salivary gland cancer	0.0006	0.0006	CbGpPWpGaD
Lansoprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—salivary gland cancer	0.000594	0.000594	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000591	0.000591	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ISYNA1—salivary gland cancer	0.000588	0.000588	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PHGDH—salivary gland cancer	0.000585	0.000585	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ST3GAL4—salivary gland cancer	0.000563	0.000563	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AQP1—salivary gland cancer	0.000562	0.000562	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.000532	0.000532	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000526	0.000526	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ISYNA1—salivary gland cancer	0.000525	0.000525	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MARCKS—salivary gland cancer	0.000523	0.000523	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.000512	0.000512	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AQP1—salivary gland cancer	0.000512	0.000512	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PYGB—salivary gland cancer	0.000486	0.000486	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ISYNA1—salivary gland cancer	0.000483	0.000483	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MARCKS—salivary gland cancer	0.000479	0.000479	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ISYNA1—salivary gland cancer	0.000479	0.000479	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000468	0.000468	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000457	0.000457	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—NUP62—salivary gland cancer	0.000446	0.000446	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PYGB—salivary gland cancer	0.000446	0.000446	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—VCAN—salivary gland cancer	0.000442	0.000442	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.00043	0.00043	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MARCKS—salivary gland cancer	0.000428	0.000428	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000418	0.000418	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.00041	0.00041	CbGpPWpGaD
Lansoprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—salivary gland cancer	0.000409	0.000409	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ISYNA1—salivary gland cancer	0.000409	0.000409	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NUP62—salivary gland cancer	0.000406	0.000406	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—VCAN—salivary gland cancer	0.000403	0.000403	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PYGB—salivary gland cancer	0.000398	0.000398	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PHGDH—salivary gland cancer	0.000396	0.000396	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MARCKS—salivary gland cancer	0.000394	0.000394	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MARCKS—salivary gland cancer	0.00039	0.00039	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000388	0.000388	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PYGB—salivary gland cancer	0.000388	0.000388	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ST3GAL4—salivary gland cancer	0.000381	0.000381	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PYGB—salivary gland cancer	0.000366	0.000366	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PHGDH—salivary gland cancer	0.000363	0.000363	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PYGB—salivary gland cancer	0.000363	0.000363	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ST3GAL4—salivary gland cancer	0.00035	0.00035	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AQP1—salivary gland cancer	0.000346	0.000346	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000338	0.000338	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000336	0.000336	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MARCKS—salivary gland cancer	0.000333	0.000333	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000327	0.000327	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PHGDH—salivary gland cancer	0.000324	0.000324	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AQP1—salivary gland cancer	0.000318	0.000318	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000316	0.000316	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000316	0.000316	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ST3GAL4—salivary gland cancer	0.000312	0.000312	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000312	0.000312	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PYGB—salivary gland cancer	0.00031	0.00031	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000305	0.000305	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000304	0.000304	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PHGDH—salivary gland cancer	0.000298	0.000298	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PHGDH—salivary gland cancer	0.000296	0.000296	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	0.000287	0.000287	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ST3GAL4—salivary gland cancer	0.000285	0.000285	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AQP1—salivary gland cancer	0.000283	0.000283	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000277	0.000277	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000277	0.000277	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NUP62—salivary gland cancer	0.000275	0.000275	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—VCAN—salivary gland cancer	0.000272	0.000272	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CREBBP—salivary gland cancer	0.000268	0.000268	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000264	0.000264	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AQP1—salivary gland cancer	0.000261	0.000261	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AQP1—salivary gland cancer	0.000258	0.000258	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000257	0.000257	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PHGDH—salivary gland cancer	0.000253	0.000253	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NUP62—salivary gland cancer	0.000252	0.000252	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—VCAN—salivary gland cancer	0.00025	0.00025	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ST3GAL4—salivary gland cancer	0.000243	0.000243	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000239	0.000239	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000239	0.000239	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CREBBP—salivary gland cancer	0.000235	0.000235	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.00023	0.00023	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NUP62—salivary gland cancer	0.000225	0.000225	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—VCAN—salivary gland cancer	0.000223	0.000223	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000223	0.000223	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AQP1—salivary gland cancer	0.000221	0.000221	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NUP62—salivary gland cancer	0.000219	0.000219	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000219	0.000219	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000218	0.000218	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NUP62—salivary gland cancer	0.000207	0.000207	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—VCAN—salivary gland cancer	0.000205	0.000205	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NUP62—salivary gland cancer	0.000205	0.000205	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—VCAN—salivary gland cancer	0.000203	0.000203	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000196	0.000196	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000196	0.000196	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000195	0.000195	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTEN—salivary gland cancer	0.000192	0.000192	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000188	0.000188	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—EP300—salivary gland cancer	0.000183	0.000183	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000182	0.000182	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000178	0.000178	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NUP62—salivary gland cancer	0.000175	0.000175	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—VCAN—salivary gland cancer	0.000174	0.000174	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CREBBP—salivary gland cancer	0.000173	0.000173	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000171	0.000171	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.00017	0.00017	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTEN—salivary gland cancer	0.000168	0.000168	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000163	0.000163	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—EP300—salivary gland cancer	0.00016	0.00016	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CREBBP—salivary gland cancer	0.000157	0.000157	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000157	0.000157	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000152	0.000152	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000149	0.000149	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.00014	0.00014	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PIK3CA—salivary gland cancer	0.000135	0.000135	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.000135	0.000135	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.000134	0.000134	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000133	0.000133	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000127	0.000127	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTEN—salivary gland cancer	0.000124	0.000124	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000122	0.000122	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.00012	0.00012	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CA—salivary gland cancer	0.000118	0.000118	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—EP300—salivary gland cancer	0.000118	0.000118	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTEN—salivary gland cancer	0.000112	0.000112	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.00011	0.00011	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000109	0.000109	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—EP300—salivary gland cancer	0.000107	0.000107	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CREBBP—salivary gland cancer	0.000106	0.000106	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000104	0.000104	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	9.86e-05	9.86e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CREBBP—salivary gland cancer	9.76e-05	9.76e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	8.99e-05	8.99e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CREBBP—salivary gland cancer	8.71e-05	8.71e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CA—salivary gland cancer	8.71e-05	8.71e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CREBBP—salivary gland cancer	8.51e-05	8.51e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CREBBP—salivary gland cancer	8.02e-05	8.02e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CREBBP—salivary gland cancer	7.95e-05	7.95e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CA—salivary gland cancer	7.93e-05	7.93e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	7.68e-05	7.68e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTEN—salivary gland cancer	7.61e-05	7.61e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—EP300—salivary gland cancer	7.25e-05	7.25e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTEN—salivary gland cancer	6.97e-05	6.97e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CREBBP—salivary gland cancer	6.79e-05	6.79e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—EP300—salivary gland cancer	6.65e-05	6.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTEN—salivary gland cancer	6.22e-05	6.22e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTEN—salivary gland cancer	6.07e-05	6.07e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—EP300—salivary gland cancer	5.94e-05	5.94e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—EP300—salivary gland cancer	5.79e-05	5.79e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTEN—salivary gland cancer	5.72e-05	5.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTEN—salivary gland cancer	5.67e-05	5.67e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—EP300—salivary gland cancer	5.46e-05	5.46e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—EP300—salivary gland cancer	5.41e-05	5.41e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CA—salivary gland cancer	5.37e-05	5.37e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CREBBP—salivary gland cancer	5.24e-05	5.24e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CA—salivary gland cancer	4.92e-05	4.92e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTEN—salivary gland cancer	4.85e-05	4.85e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—EP300—salivary gland cancer	4.62e-05	4.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CA—salivary gland cancer	4.39e-05	4.39e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CA—salivary gland cancer	4.29e-05	4.29e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	4.04e-05	4.04e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CA—salivary gland cancer	4e-05	4e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTEN—salivary gland cancer	3.74e-05	3.74e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—EP300—salivary gland cancer	3.57e-05	3.57e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CA—salivary gland cancer	3.42e-05	3.42e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	2.64e-05	2.64e-05	CbGpPWpGaD
